Patient selection for elective revascularization to reduce myocardial infarction and mortality: new lessons from randomized trials, coronary physiology, and statistics

K Lance Gould; Nils P Johnson; Sanjay Kaul; Richard L Kirkeeide; Gary S Mintz; K Peter Rentrop; Stefano Sdringola; Renu Virmani; Jagat Narula

doi:10.1161/CIRCIMAGING.114.003099

Patient selection for elective revascularization to reduce myocardial infarction and mortality: new lessons from randomized trials, coronary physiology, and statistics

Circ Cardiovasc Imaging. 2015 May;8(5):e003099. doi: 10.1161/CIRCIMAGING.114.003099.

Authors

K Lance Gould¹, Nils P Johnson², Sanjay Kaul², Richard L Kirkeeide², Gary S Mintz², K Peter Rentrop², Stefano Sdringola², Renu Virmani², Jagat Narula²

Affiliations

¹ From the Division of Cardiology, Department of Medicine, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Medical School at Houston and Memorial Hermann Hospital (K.L.G., N.P.J., R.L.K., S.S.); Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, CA (S.K.); Cardiovascular Research Foundation, New York, NY (G.S.M.); Department of Medicine, Cardiovascular Disease, New York Presbyterian Hospital, The University Hospital of Columbia and Cornell, New York (K.P.R.); Division of Cardiology, Department of Medicine, NY Langone Medical Center, New York (K.P.R.); Gramercy Cardiac Diagnostic Services, New York, NY (K.P.R.); CVPath Institute Inc, Gaithersburg, MD (R.V.); and Zena and Michael A. Weiner Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY (J.N.). K.Lance.Gould@uth.tmc.edu.
² From the Division of Cardiology, Department of Medicine, Weatherhead PET Center for Preventing and Reversing Atherosclerosis, University of Texas Medical School at Houston and Memorial Hermann Hospital (K.L.G., N.P.J., R.L.K., S.S.); Division of Cardiology, Cedars-Sinai Medical Center, Los Angeles, CA (S.K.); Cardiovascular Research Foundation, New York, NY (G.S.M.); Department of Medicine, Cardiovascular Disease, New York Presbyterian Hospital, The University Hospital of Columbia and Cornell, New York (K.P.R.); Division of Cardiology, Department of Medicine, NY Langone Medical Center, New York (K.P.R.); Gramercy Cardiac Diagnostic Services, New York, NY (K.P.R.); CVPath Institute Inc, Gaithersburg, MD (R.V.); and Zena and Michael A. Weiner Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY (J.N.).

PMID: 25977304
DOI: 10.1161/CIRCIMAGING.114.003099

No abstract available

Keywords: coronary stenosis; percutaneous coronary intervention.

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Coronary Artery Disease / mortality*
Coronary Artery Disease / physiopathology
Coronary Artery Disease / therapy*
Data Interpretation, Statistical
Humans
Myocardial Infarction / mortality*
Myocardial Infarction / physiopathology
Myocardial Infarction / prevention & control*
Myocardial Revascularization / methods*
Patient Selection*
Percutaneous Coronary Intervention*
Practice Guidelines as Topic
Randomized Controlled Trials as Topic

Associated data

ClinicalTrials.gov/NCT02184117
ClinicalTrials.gov/NCT02328820